SNCA and Parkinson disease: In the PD model, a sixfold increase was found in the SN of WT mice at 15 days post-injection of AAV2-CBA-α-synuclein (P = 0.0037 versus control), whereas the levels measured in AAV-null injected animals at the same time point did not differ from control values (Fig. 3A).